The following excerpt was taken from slide 8 of a Volpara presentation lodged 2nd September.
ARPU for VolparaEnterprise alone has been rising organically, and in FY19 was US$2.20, 37% higher than FY18. In Q1, contracts signed ranged up to an ARPU of US$7 – the aim with MRS and other products is to get to US$10 and beyond.
So we can see intention is to lift over time the average revenue per user to US$10 with the benefit of the MRS acquisition. I don’t have a break even forecast but believe the size of the opportunity makes that possible with proper execution.